Literature DB >> 21732409

Resolution of inflammation by N-arachidonoylglycine.

Sumner H Burstein1, Catherine A McQuain, Alonzo H Ross, Rebecca A Salmonsen, Robert E Zurier.   

Abstract

N-arachidonoylglycine (NAgly) is an endogenous signaling lipid that is a member of the eicosanoid super family and is related to anandamide. It shows anti-inflammatory activity in vivo in the mouse peritonitis model where it reduces migration of inflammatory leukocytes following injection of pro-inflammatory agents into the peritoneal cavity. Using cell culture models, including GPR18 transfected HEK-293 cells, evidence is presented that the orphan receptor GPR18 is involved in this action. Increases in free arachidonic acid, and robust stimulation of anti-inflammatory eicosanoids were observed at low micromolar concentrations. These included 15-deoxy-delta-13,14-PGJ(2) and lipoxin A(4) both of which are believed to mediate the resolution stage of inflammation. It was further shown that NAgly might act via GPR18 activation in promoting the number of Trypan Blue stained cells, a possible indicator of programmed cell death. Thus, we hypothesize that NAgly induces the death of inflammatory cells, a process that is considered to be important for the resolution of inflammation.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732409      PMCID: PMC3196844          DOI: 10.1002/jcb.23245

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  22 in total

1.  Inducible cyclooxygenase may have anti-inflammatory properties.

Authors:  D W Gilroy; P R Colville-Nash; D Willis; J Chivers; M J Paul-Clark; D A Willoughby
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

Review 2.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

3.  Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.

Authors:  T Sheskin; L Hanus; J Slager; Z Vogel; R Mechoulam
Journal:  J Med Chem       Date:  1997-02-28       Impact factor: 7.446

Review 4.  Old and new generation lipid mediators in acute inflammation and resolution.

Authors:  Melanie J Stables; Derek W Gilroy
Journal:  Prog Lipid Res       Date:  2010-07-23       Impact factor: 16.195

5.  Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain.

Authors:  S M Huang; T Bisogno; T J Petros; S Y Chang; P A Zavitsanos; R E Zipkin; R Sivakumar; A Coop; D Y Maeda; L De Petrocellis; S Burstein; V Di Marzo; J M Walker
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

Review 6.  Positioning prostanoids of the D and J series in the immunopathogenic scheme.

Authors:  J L Herlong; T R Scott
Journal:  Immunol Lett       Date:  2005-11-04       Impact factor: 3.685

7.  Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.

Authors:  Masashi Kohno; Hitoshi Hasegawa; Atsushi Inoue; Masatake Muraoka; Tatsuhiko Miyazaki; Keizo Oka; Masaki Yasukawa
Journal:  Biochem Biophys Res Commun       Date:  2006-07-10       Impact factor: 3.575

8.  The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system.

Authors:  V K Pestonjamasp; S H Burstein
Journal:  Biochim Biophys Acta       Date:  1998-11-02

Review 10.  Arachidonic acid metabolism: role in inflammation.

Authors:  B Samuelsson
Journal:  Z Rheumatol       Date:  1991       Impact factor: 1.372

View more
  24 in total

Review 1.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

Authors:  D McHugh
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 2.  Endocannabinoid signaling pathways: beyond CB1R and CB2R.

Authors:  Roger Gregory Biringer
Journal:  J Cell Commun Signal       Date:  2021-05-12       Impact factor: 5.782

3.  Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2017-12-20       Impact factor: 4.432

4.  N-Amino acid linoleoyl conjugates: anti-inflammatory activities.

Authors:  Sumner Burstein; Catherine McQuain; Rebecca Salmonsen; Benjamin Seicol
Journal:  Bioorg Med Chem Lett       Date:  2011-12-16       Impact factor: 2.823

5.  Asymmetric synthesis of novel N-(1-phenyl-2,3-dihydroxypropyl)arachidonylamides and evaluation of their anti-inflammatory activity.

Authors:  Padmanabha V Kattamuri; Rebecca Salmonsen; Catherine McQuain; Sumner Burstein; Hao Sun; Guigen Li
Journal:  Life Sci       Date:  2012-07-20       Impact factor: 5.037

6.  N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice.

Authors:  Giulia Donvito; Fabiana Piscitelli; Pretal Muldoon; Asti Jackson; Rosa Maria Vitale; Enrico D'Aniello; Catia Giordano; Bogna M Ignatowska-Jankowska; Mohammed A Mustafa; Francesca Guida; Gavin N Petrie; Linda Parker; Reem Smoum; Laura Sim-Selley; Sabatino Maione; Aron H Lichtman; M Imad Damaj; Vincenzo Di Marzo; Raphael Mechoulam
Journal:  Neuropharmacology       Date:  2018-03-19       Impact factor: 5.250

7.  Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine.

Authors:  Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Inflamm Res       Date:  2012-01-18       Impact factor: 4.575

8.  N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways.

Authors:  Van B Lu; Henry L Puhl; Stephen R Ikeda
Journal:  Mol Pharmacol       Date:  2012-10-25       Impact factor: 4.436

9.  N-FATTY ACYLGLYCINES: UNDERAPPRECIATED ENDOCANNABINOID-LIKE FATTY ACID AMIDES?

Authors:  Ryan L Anderson; David J Merkler
Journal:  J Biol Nat       Date:  2018-03-03

Review 10.  The cannabinoid acids, analogs and endogenous counterparts.

Authors:  Sumner H Burstein
Journal:  Bioorg Med Chem       Date:  2014-04-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.